发明授权
US09000041B2 Hydroxyl compounds and compositions for cholesterol management and related uses
有权
用于胆固醇管理和相关用途的羟基化合物和组合物
- 专利标题: Hydroxyl compounds and compositions for cholesterol management and related uses
- 专利标题(中): 用于胆固醇管理和相关用途的羟基化合物和组合物
-
申请号: US13925818申请日: 2013-06-24
-
公开(公告)号: US09000041B2公开(公告)日: 2015-04-07
- 发明人: Jean-Louis Henri Dasseux , Carmen Daniela Oniciu
- 申请人: Jean-Louis Henri Dasseux , Carmen Daniela Oniciu
- 申请人地址: US MI Ann Arbor
- 专利权人: Esperion Therapeutics, Inc.
- 当前专利权人: Esperion Therapeutics, Inc.
- 当前专利权人地址: US MI Ann Arbor
- 代理机构: Goodwin Procter LLP
- 主分类号: A61K31/20
- IPC分类号: A61K31/20 ; C07C59/245 ; C07C31/20 ; C07C31/22 ; C07C31/24 ; C07C59/11 ; C07C59/285 ; C07C59/29 ; C07C59/46 ; C07C59/48 ; C07C59/54 ; C07C62/02 ; C07C62/06 ; C07C65/17 ; C07C69/757 ; C07D213/80 ; C07D309/10 ; C07D309/12 ; C07D405/12 ; C07F9/09 ; C07F9/117 ; C07F9/24 ; C07F9/44
摘要:
The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
公开/授权文献
信息查询
IPC分类: